Home / Business and Economy / Pharma Giant's Global Reach Revealed
Pharma Giant's Global Reach Revealed
13 Aug
Summary
- Aurobindo Pharma focuses on active ingredients and generic drugs.
- Net sales driven by U.S. (46.5%) and Europe (31.2%).
- Operates 23 production sites across India, U.S., and Brazil.
Aurobindo Pharma is a significant player in the pharmaceutical industry, concentrating on the research, development, manufacturing, and marketing of active pharmaceutical ingredients and generic drugs. The company's product portfolio addresses treatments for neurological, cardiovascular, viral, gastroenterological, and ophthalmologic conditions, as well as chronic diseases.
As of March 2018, Aurobindo Pharma operated a substantial network of 23 production facilities. These sites were strategically located across India, with 19 facilities, alongside 3 in the United States and 3 in Brazil.
The company's revenue streams are geographically diverse, with the United States contributing the largest share of net sales at 46.5%. Europe follows as a key market, accounting for 31.2% of net sales. India represents 12% of net sales, with other regions making up the remaining 10.3%.
